Furthermore, whether HuR’s effects on growth, proliferation, and apoptosis differ at various stages of CRC progression (from early to late stages) remains to be determined, which will be crucial for developing targeted therapeutic strategies. Here, ELAVL1 is linked to colorectal carcinoma.